Aleve (Naproxen Sodium) Dosage Calculator

How the Aleve Dosage Calculator Works

The Aleve dosage calculator applies evidence-based naproxen sodium dosing rules across four distinct clinical scenarios: over-the-counter (OTC) standard use, OTC loading doses, prescription (Rx) standard doses, and prescription high doses. A separate pediatric weight-based formula covers juvenile rheumatoid arthritis (JRA). The tool enforces FDA-aligned age-based safety cutoffs throughout. This calculator synthesizes FDA labeling, clinical trial data, and published NSAID safety guidance to help patients and healthcare providers determine appropriate naproxen sodium doses that balance therapeutic efficacy with safety considerations across different age groups and clinical conditions.

Naproxen Sodium Dosing Formula

The formula selects a dose in milligrams based on three variables — age, weight, and clinical indication. Each tier reflects published labeling and clinical trial protocols:

• Age under 2 years: 0 mg — naproxen sodium is contraindicated in infants and toddlers under age 2.
• Pediatric JRA (weight-based): Dose (mg) = min(5 × weight in kg, 500 mg). A 20 kg child receives 100 mg; a child exceeding 100 kg is capped at 500 mg.
• OTC Standard dose: 220 mg per dose (one Aleve tablet). Approved for adults and children aged 12 and older.
• OTC Loading dose (age under 65): 440 mg (two 220 mg tablets) as a first dose, followed by 220 mg every 8 to 12 hours.
• Prescription Standard (Anaprox): 275 mg per dose — one tablet of naproxen sodium 275 mg.
• Prescription High dose (age under 65): 550 mg per dose — one tablet of naproxen sodium 550 mg.

The tier system is built on pharmacokinetic principles: older adults have reduced hepatic metabolism and renal clearance, making them more susceptible to NSAID accumulation and toxicity. Thus, loading doses and high-dose tiers are restricted in this population. Younger adults with normal organ function tolerate higher initial and maximum doses, which hastens onset of pain relief in acute conditions. Weight-based pediatric dosing for JRA ensures efficacy while minimizing systemic exposure in growing patients whose body composition and drug metabolism differ significantly from adults.

Key Variables Explained

Age

Patient age governs both safety eligibility and dose tier. Naproxen sodium is not recommended for children under 2 years. OTC use is approved for patients aged 12 and older. Patients aged 65 and older should avoid loading doses and high-dose prescription regimens due to elevated risk of gastrointestinal bleeding and renal impairment, consistent with FDA labeling and NSAID safety guidance from the Uniformed Services University NSAID dosing guide. Age-related physiologic changes including reduced gastric mucosal thickness, declining renal function, and altered drug distribution are the primary drivers of this differentiation.

Weight

Weight in pounds is converted internally to kilograms (1 lb = 0.4536 kg) for the pediatric JRA calculation. The formula of 5 mg per kilogram aligns with clinical dosing guidelines for juvenile arthritis, with a hard cap of 500 mg to prevent toxicity in heavier pediatric patients. This weight-based approach is particularly important in pediatric practice because drug clearance and distribution volumes scale with body weight more predictably in children than fixed-dose regimens.

Indication and Dosing Strategy

The indication field determines which dose tier applies. OTC Aleve tablets each contain 220 mg naproxen sodium. Prescription Anaprox tablets come in 275 mg and 550 mg strengths, as documented in the Certified Medication Technician Student Manual. OTC and Rx formulations are not interchangeable on a milligram-for-milligram basis without physician direction. The selection of indication is critical because it directly determines which dose tier the calculator applies, ultimately controlling the maximum allowable daily dose and dosing interval.

Clinical Use Cases and Examples

Example 1 — Adult OTC Use

A 35-year-old adult seeking OTC pain relief takes a 440 mg loading dose (two Aleve tablets) then 220 mg every 8 to 12 hours. Maximum OTC daily dose: 660 mg per 24 hours unless a physician directs otherwise.

Example 2 — Pediatric JRA

A 10-year-old child weighing 66 lb (30 kg) with juvenile rheumatoid arthritis receives: 5 mg/kg × 30 kg = 150 mg per dose, well below the 500 mg safety cap. This weight-based approach is validated by the NCT02519231 OTC naproxen sodium clinical trial protocol and published pediatric NSAID research.

Example 3 — Senior OTC Use

A 70-year-old patient uses OTC Aleve at the standard 220 mg dose only. The 440 mg loading dose tier is excluded for patients aged 65 and older to reduce cardiovascular and renal risk, and prescribers often recommend additional monitoring in this population.

Example 4 — Pediatric OTC Use

A 14-year-old adolescent weighing 110 lb uses OTC Aleve at the standard 220 mg dose for mild headache. Age-based eligibility is the deciding factor here: once a patient reaches 12 years old, the standard OTC dose becomes available regardless of weight, reflecting the lower toxicity risk in younger patients with normal organ function compared to very young children or geriatric populations.

Important Safety Notes

Naproxen sodium is an NSAID and carries risks including gastrointestinal ulcers, cardiovascular events, and kidney damage with prolonged or high-dose use. NSAIDs inhibit prostaglandin synthesis, which protects the stomach lining, maintains renal blood flow, and supports platelet function; long-term use disrupts these protective mechanisms. Additionally, naproxen sodium has a long half-life of 12–17 hours, meaning doses accumulate with frequent dosing, further increasing toxicity risk in susceptible populations. Always consult a licensed healthcare provider before starting, adjusting, or prolonging any naproxen sodium regimen. The doses shown reflect general labeling guidelines and do not substitute for individualized medical advice. Patients with a history of ulcers, cardiovascular disease, chronic kidney disease, or those taking anticoagulants should never self-medicate with NSAIDs and must seek physician approval before use.